Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Honoring the Past and Leading the Future (): A Report on the 46th Annual Meeting of the Japanese Society for Apheresis.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same author

Association between specialist distribution and peritoneal dialysis use in Japan: An ecological study.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

New-onset Diabetes among Japanese University Enrollees: Role of Preceding Non-communicable Disorders.

Internal medicine (Tokyo, Japan)·2026
Same author

Elevation of non-esterified fatty acids induced by hemodialysis sessions : pathophysiology and management strategies.

Fukushima journal of medical science·2026
Same author

Association Between Specialist Distribution and Regional Variation in Plasmapheresis Use in Japan: A Population-Level Cross-Sectional Study.

Journal of clinical apheresis·2026
Same author

Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS).

Arthritis research & therapy·2026

Related Experiment Video

Updated: Jul 7, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Peritoneal damage by peritoneal dialysis solutions.

Takafumi Ito1, Noriaki Yorioka2

  • 1Section of Nephrology, Department of Internal Medicine, Faculty of Medicine, Shimane University, 85-1, Enya-cho, Izumo, 693-8501, Japan.

Clinical and Experimental Nephrology
|February 16, 2008
PubMed
Summary

Continuous ambulatory peritoneal dialysis (CAPD) is limited by peritoneal sclerosis, often caused by low biocompatibility of dialysis solutions. This review examines experimental data on the biocompatibility of these solutions.

More Related Videos

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Related Experiment Videos

Last Updated: Jul 7, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Medical Technology

Background:

  • Continuous ambulatory peritoneal dialysis (CAPD) is a common treatment for end-stage renal disease.
  • Long-term CAPD success is often compromised by peritoneal sclerosis.
  • The biocompatibility of peritoneal dialysis solutions is implicated in sclerosis development.

Purpose of the Study:

  • To review recent experimental findings on the biocompatibility of peritoneal dialysis solutions.
  • To highlight the role of solution biocompatibility in peritoneal sclerosis.
  • To inform strategies for improving long-term CAPD outcomes.

Main Methods:

  • Literature review of experimental studies.
  • Analysis of data on peritoneal dialysis solution properties.
  • Synthesis of evidence linking solution characteristics to peritoneal sclerosis.

Main Results:

  • Low biocompatibility of current peritoneal dialysis solutions is a significant factor in peritoneal sclerosis.
  • Specific components and properties of dialysis solutions influence biocompatibility.
  • Experimental data provides insights into the mechanisms of sclerosis.

Conclusions:

  • Improving the biocompatibility of peritoneal dialysis solutions is crucial for mitigating peritoneal sclerosis.
  • Further research into solution design can enhance long-term CAPD efficacy.
  • Addressing solution biocompatibility is key to advancing peritoneal dialysis treatment.